Literature DB >> 30731316

A comprehensive and unified framework for analysing the effects on injuries of measures influencing speed.

Rune Elvik1.   

Abstract

This paper proposes a comprehensive and unified framework for analysing the impacts on traffic injury of measures influencing speed. The key tool for analysis is a specification of the speed distribution, which in most cases closely approximates a standard normal distribution. The speed distribution can be represented, for example, by twelve intervals each comprising one half standard deviation. The exponential model of the relationship between speed and the number of injured road users is applied to estimate the expected injury rate for drivers travelling at the mean speed of any part of the distribution. The relationship between individual driver speed and accident involvement is then incorporated into the speed distribution. A speed distribution specified this way represents both the mean speed of traffic and the variation in speed-related risk between drivers. Impacts of changes in speed that can be modelled include: (1) Shifting the whole speed distribution, (2) Compressing the upper end of the speed distribution, (3) Enlarging or reducing the variance of the speed distribution, (4) Selective changes in specific regions of the speed distribution. Examples are given of how knowledge of the impacts of measures on speed can be translated into expected changes in the number of injured road users by relying on the analytic framework.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Keywords:  Analytic framework; Distribution; Exponential model; Speed; Variance

Mesh:

Year:  2019        PMID: 30731316     DOI: 10.1016/j.aap.2019.01.033

Source DB:  PubMed          Journal:  Accid Anal Prev        ISSN: 0001-4575


  1 in total

1.  Evaluating the citywide Edinburgh 20mph speed limit intervention effects on traffic speed and volume: A pre-post observational evaluation.

Authors:  Glenna F Nightingale; Andrew James Williams; Ruth F Hunter; James Woodcock; Kieran Turner; Claire L Cleland; Graham Baker; Michael Kelly; Andy Cope; Frank Kee; Karen Milton; Charlie Foster; Ruth Jepson; Paul Kelly
Journal:  PLoS One       Date:  2021-12-31       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.